| |
KOMISJA NADZORU FINANSOWEGO |
|
| |
|
|
Raport bieżący nr |
4 |
/ |
2023 |
|
|
|
| |
Data sporządzenia: |
2023-03-14 |
|
|
|
|
|
|
|
|
|
| |
Skrócona nazwa emitenta |
|
|
|
|
|
|
|
|
|
| |
MILESTONE MEDICAL |
|
| |
Temat |
|
|
|
|
|
|
|
|
|
|
| |
Commencing sales of CompuFlo Epidural disposables within the University Pain and Spine
Center which operates 7 locations across New Jersey and New York
|
|
| |
Podstawa prawna |
|
|
|
|
|
|
|
|
| |
Art. 17 ust. 1 MAR - informacje poufne.
|
|
| |
Treść raportu: |
|
|
|
|
|
|
|
|
|
| |
The Board of Directors of Milestone Medical Inc. _WAR: MMD, "the Company", "the Issuer"_,
today announced that it has commenced sales of CompuFlo Epidural disposables into
the University Pain and Spine Center, which operates 7 offices across New Jersey and
New York. Adoption of the technology follows a successful evaluation by Dr. Didier
Demesmin, MD, MBA. Dr. Demesmin is an interventional pain medicine physician who
is board-certified in both anesthesiology and pain medicine. He is also the medical
director and founder of the University Pain and Spine Center and is also affiliated
with some of the most well-respected hospitals in Central New Jersey, such as Robert
Wood Johnson University Hospital, JFK Medical Center, Somerset Medical Center, and
Saint Peter's University Hospital, where he is the director of pain medicine.
The Board of Directors of the Company is delighted by the recent adoption of the technology
by the University Pain and Spine Center following a successful evaluation period.
The Board of Directors of the Company believes that the ability of the instrument
to objectively measure tissue density, as well as provide both visual and audible
confirmation of needle placement, can enhance both the speed and safety of the procedure,
thereby providing a better experience for the provider and patient.
|
|
|
RB_ASO: Commencing sales of CompuFlo Epidural disposables within the University Pain and Spine
Center which operates 7 locations across New Jersey and New York 
